Jihad Snobre

ORCID

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Venues

BMJ open

This page only lists publications with an associated author ORCID identifier.

Publications

Jihad Snobre, Joel Gasana, Jean Claude Semuto Ngabonziza, Isabel Cuella Martin, Leen Rigouts, Bart Karl Jacobs, Emeline de Viron, Natacha Herssens, Jean Baptiste Ntihumby, Annualithe Klibazayre, Clement Ndayishimiye, Armand Van Deun, Dissou Affolabi, Corinne S Merle, Claude Muvunyi, Marieke G G Sturkenboom, Patrick Migambi, Bouke C de Jong, Yves Mucyo, Tom Decroo
Safety of high-dose amikacin in the first week of all-oral rifampicin-resistant tuberculosis treatment for the prevention of acquired resistance (STAKE): protocol for a single-arm clinical trial. BMJ open 14 (7) (2024)
Jihad Snobre, Joel Gasana, Jean Claude Semuto Ngabonziza, Isabel Cuella Martin, Leen Rigouts, Bart Karl Jacobs, Emeline de Viron, Natacha Herssens, Jean Baptiste Ntihumby, Annualithe Klibazayre, Clement Ndayishimiye, Armand Van Deun, Dissou Affolabi, Corinne S Merle, Claude Muvunyi, Marieke G G Sturkenboom, Patrick Migambi, Bouke C de Jong, Yves Mucyo, Tom Decroo
Safety of high-dose amikacin in the first week of all-oral rifampicin-resistant tuberculosis treatment for the prevention of acquired resistance (STAKE): protocol for a single-arm clinical trial. BMJ open 14 (7) (2024)
Jihad Snobre, Joel Gasana, Jean Claude Semuto Ngabonziza, Isabel Cuella Martin, Leen Rigouts, Bart Karl Jacobs, Emeline de Viron, Natacha Herssens, Jean Baptiste Ntihumby, Annualithe Klibazayre, Clement Ndayishimiye, Armand Van Deun, Dissou Affolabi, Corinne S Merle, Claude Muvunyi, Marieke G G Sturkenboom, Patrick Migambi, Bouke C de Jong, Yves Mucyo, Tom Decroo
Safety of high-dose amikacin in the first week of all-oral rifampicin-resistant tuberculosis treatment for the prevention of acquired resistance (STAKE): protocol for a single-arm clinical trial. BMJ open 14 (7) (2024)
Jihad Snobre, Joel Gasana, Jean Claude Semuto Ngabonziza, Isabel Cuella Martin, Leen Rigouts, Bart Karl Jacobs, Emeline de Viron, Natacha Herssens, Jean Baptiste Ntihumby, Annualithe Klibazayre, Clement Ndayishimiye, Armand Van Deun, Dissou Affolabi, Corinne S Merle, Claude Muvunyi, Marieke G G Sturkenboom, Patrick Migambi, Bouke C de Jong, Yves Mucyo, Tom Decroo
Safety of high-dose amikacin in the first week of all-oral rifampicin-resistant tuberculosis treatment for the prevention of acquired resistance (STAKE): protocol for a single-arm clinical trial. BMJ open 14 (7) (2024)

Jihad Snobre.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jihad Snobre